Multireader Study on the Diagnostic Accuracy of Ultrafast Breast Magnetic Resonance Imaging for Breast Cancer Screening

被引:59
|
作者
van Zelst, Jan C. M. [1 ]
Vreemann, Suzan [1 ]
Witt, Hans-Joerg [2 ]
Gubern-Merida, Albert [1 ]
Dorrius, Monique D. [3 ]
Duvivier, Katya [4 ]
Lardenoije-Broker, Susanne [1 ]
Lobbes, Marc B. I. [5 ]
Loo, Claudette [6 ]
Veldhuis, Wouter [7 ]
Veltman, Jeroen [8 ]
Drieling, Daniel [2 ]
Karssemeijer, Nico [1 ]
Mann, Ritse M. [1 ]
机构
[1] Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Internal Route 766,Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands
[2] MeVis Med Solut, Bremen, Germany
[3] Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Radiol, Amsterdam, Netherlands
[5] Maastricht Univ, Med Ctr, Dept Radiol & Nucl Med, Maastricht, Netherlands
[6] Netherlands Canc Inst, Dept Radiol, Utrecht, Netherlands
[7] Univ Med Ctr, Dept Radiol, Utrecht, Netherlands
[8] ZGT Med Ctr, Dept Radiol, Almelo, Netherlands
关键词
breast MRI; screening; breast cancer; ultrafast breast MRI; abbreviated breast MRI; multireader; multicase study; HIGH FAMILIAL RISK; COST-EFFECTIVENESS; MUTATION CARRIERS; MRI; WOMEN; MAMMOGRAPHY; BRCA1; PROTOCOL; SOCIETY; POPULATION;
D O I
10.1097/RLI.0000000000000494
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives: Breast cancer screening using magnetic resonance imaging (MRI) has limited accessibility due to high costs of breast MRI. Ultrafast dynamic contrast-enhanced breast MRI can be acquired within 2 minutes. We aimed to assess whether screening performance of breast radiologist using an ultrafast breast MRI-only screening protocol is as good as performance using a full multiparametric diagnostic MRI protocol (FDP). Materials and Methods: The institutional review board approved this study, and waived the need for informed consent. Between January 2012 and June 2014, 1791 consecutive breast cancer screening examinations from 954 women with a lifetime risk of more than 20% were prospectively collected. All women were scanned using a 3 T protocol interleaving ultrafast breast MRI acquisitions in a full multiparametric diagnostic MRI protocol consisting of standard dynamic contrast-enhanced sequences, diffusion-weighted imaging, and T2-weighted imaging. Subsequently, a case set was created including all biopsied screen-detected lesions in this period (31 malignant and 54 benign) and 116 randomly selected normal cases with more than 2 years of follow-up. Prior examinations were included when available. Seven dedicated breast radiologists read all 201 examinations and 153 available priors once using the FDP and once using ultrafast breast MRI only in 2 counterbalanced and crossed-over reading sessions. Results: For reading the FDP versus ultrafast breast MRI alone, sensitivity was 0.86 (95% confidence interval [CI], 0.81-0.90) versus 0.84 (95% CI, 0.78-0.88) (P = 0.50), specificity was 0.76 (95% CI, 0.74-0.79) versus 0.82 (95% CI, 0.79-0.84) (P = 0.002), positive predictive value was 0.40 (95% CI, 0.36-0.45) versus 0.45 (95% CI, 0.41-0.50) (P = 0.14), and area under the receiver operating characteristics curve was 0.89 (95% CI, 0.82-0.96) versus 0.89 (95% CI, 0.82-0.96) (P = 0.83). Ultrafast breast MRI reading was 22.8% faster than reading FDP (P < 0.001). Interreader agreement is significantly better for ultrafast breast MRI (kappa = 0.730; 95% CI, 0.699-0.761) than for the FDP (kappa = 0.665; 95% CI, 0.633-0.696). Conclusions: Breast MRI screening using only an ultrafast breast MRI protocol is noninferior to screening with an FDP and may result in significantly higher screening specificity and shorter reading time.
引用
收藏
页码:579 / 586
页数:8
相关论文
共 50 条
  • [41] Screening with Magnetic Resonance Imaging in women at low and intermediate risk of breast Cancer
    T T Huzarski
    B Górecka-Szyld
    J J Huzarska
    G Psut
    G Wilk
    R Sibilski
    C Cybulski
    B Kozak-Klonowska
    M Siołek
    E Kilar
    D Czudowska
    H Janiszewska
    D Godlewski
    A Mackiewicz
    J Jarkiewicz-Tretyn
    I Szabo-Moskal
    J Gronwald
    J Lubiński
    SA Narod
    Hereditary Cancer in Clinical Practice, 10 (Suppl 4)
  • [42] Magnetic resonance imaging for screening of women at high risk for hereditary breast cancer
    Mokbel, K
    Elkak, AE
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (21) : 4184 - 4184
  • [44] Breast imaging technology Application of magnetic resonance imaging to angiogenesis in breast cancer
    Martin O Leach
    Breast Cancer Research, 3
  • [45] Magnetic-resonance imaging for breast cancer
    Drew, PJ
    Turnbull, LW
    Kerin, MJ
    LANCET, 1998, 351 (9116): : 1661 - 1662
  • [46] Magnetic resonance imaging in breast cancer recurrence
    Belli, P
    Costantini, M
    Romani, M
    Marano, P
    Pastore, G
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 73 (03) : 223 - 235
  • [47] Imaging in breast cancer: Magnetic resonance spectroscopy
    Patrick J Bolan
    Michael T Nelson
    Douglas Yee
    Michael Garwood
    Breast Cancer Research, 7
  • [48] Magnetic-resonance imaging in breast cancer
    Boggis, CRM
    Bundred, NJ
    LANCET, 1998, 351 (9112): : 1362 - 1362
  • [49] Magnetic Resonance Perfusion Imaging for Breast Cancer
    Udayakumar, Durga
    Madhuranthakam, Ananth J.
    Dogan, Basak E.
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2024, 32 (01) : 135 - 150
  • [50] Magnetic resonance imaging of invasive breast cancer
    Corr, P.
    Panday, S.
    Seolall, P.
    Booth, H.
    SA JOURNAL OF RADIOLOGY, 2005, 9 (03): : 4 - 6